Two-hour post-load plasma glucose levels are associated with carotid intima-media thickness in subjects with normal glucose tolerance

Diabetic Medicine

Volumn 31, Issue 1, 2014, Pages 76-83

  Kato, K ^a,b   Otsuka, T ^b   Kobayashi, N ^c   Kon, Y ^c   Kawada, T ^b  

^a GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c FUJI HEAVY INDUSTRIES LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; B SCAN; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST;

ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CAROTID INTIMA-MEDIA THICKNESS; CORONARY ARTERY DISEASE; FASTING; FEMALE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TIME FACTORS;

EID: 84890138074     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12288     Document Type: Article

References (33)

1. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993. Diabetes Care 1998; 21: 1138-1145.
2. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999; 48: 937-942.
3. Doi Y, Ninomiya T, Hata J, Fukuhara M, Yonemoto K, Iwase M et al. Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study. Stroke 2010; 41: 203-209.
4. Unwin N, Shaw J, Zimmet P, Alberti KG. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002; 19: 708-723.
5. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E et al.; Emerging Risk Factors Collboration Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010; 375: 2215-2222.
6. Ning F, Tuomilehto J, Pyorala K, Onat A, Soderberg S, Qiao Q et al. Cardiovascular disease mortality in Europeans in relation to fasting and 2-h plasma glucose levels within a normoglycemic range. Diabetes Care 2010; 33: 2211-2216.
7. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14-22.
8. Hodis HN, Mack WJ, LaBree L, Selzer RH, Liu CR, Liu CH et al. The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med 1998; 128: 262-269.
9. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96: 1432-1437.
10. Succurro E, Marini MA, Arturi F, Grembiale A, Lugara M, Andreozzi F et al. Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 2009; 207: 245-249.
11. Bobbert T, Mai K, Fischer-Rosinsky A, Pfeiffer AF, Spranger J. A1C is associated with intima-media thickness in individuals with normal glucose tolerance. Diabetes Care 2010; 33: 203-204.
12. Huang Y, Bi Y, Wang W, Xu M, Xu Y, Li M et al. Glycated hemoglobin A1c, fasting plasma glucose, and two-hour postchallenge plasma glucose levels in relation to carotid intima-media thickness in chinese with normal glucose tolerance. J Clin Endocrinol Metab 2011; 96: E1461-1465.
13. Venkataraman V, Amutha A, Anbalagan VP, Deepa M, Anjana RM, Unnikrishnan R et al. Association of glycated hemoglobin with carotid intimal medial thickness in Asian Indians with normal glucose tolerance. J Diabetes Complications 2012; 26: 526-530.
14. Kashiwagi A. International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values. Diabetol Int 2012; 3: 8-10.
15. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-992.
16. WHO. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. Geneva: World Health Organization, 2006.
17. WHO. Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation. Geneva: World Health Organization, 2011.
18. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr 2008; 21: 93-111; quiz 189-190.
19. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-1406.
20. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J Hypertens 2002; 20: 159-169.
21. Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res 2009; 335: 165-189.
22. Kim JA, Montagnani M, Koh KK, Quon MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. Circulation 2006; 113: 1888-1904.
23. Karabulut A, Iltumur K, Toprak N, Tuzcu AK, Kara IH, Kaplan A et al. Insulin response to oral glucose loading and coronary artery disease in nondiabetics. Int Heart J 2005; 46: 761-770.
24. An X, Yu D, Zhang R, Zhu J, Du R, Shi Y et al. Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study. Cardiovasc Diabetol 2012; 11: 71.
25. Wang H, Hu B, Lu W, Liu F, Feng B. The relationship of angiographically defined coronary artery disease with insulin sensitivity and secretion in subjects with different glucose tolerance. J Cardiol 2012; 60: 367-371.
26. Ning F, Zhang L, Dekker JM, Onat A, Stehouwer CD, Yudkin JS et al. Development of coronary heart disease and ischemic stroke in relation to fasting and 2-hour plasma glucose levels in the normal range. Cardiovasc Diabetol 2012; 11: 76.
27. Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med 1991; 229: 225-231.
28. Wang TJ, Nam BH, Wilson PW, Wolf PA, Levy D, Polak JF et al. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2002; 22: 1662-1667.
29. Makita S, Nakamura M, Hiramori K. The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population. Stroke 2005; 36: 2138-2142.
30. Lorenz MW, Karbstein P, Markus HS, Sitzer M. High-sensitivity C-reactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study. Stroke 2007; 38: 1774-1779.
31. Kawada T, Otsuka T, Endo T, Kon Y. Aging, components of metabolic syndrome and serum C-reactive protein showed significant relationship with carotid atherosclerosis. Aging Male 2012; 15: 42-47.
32. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA et al. 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010; 56: e50-103.
33. Nambi V, Chambless L, Folsom AR, He M, Hu Y, Mosley T et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol 2010; 55: 1600-1607.